Ortin Laboratories (BOM:539287) Ending Cash Position : ₹0.00 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Ortin Laboratories Ending Cash Position?

Ortin Laboratories's Ending Cash Position for the quarter that ended in Mar. 2024 was ₹0.00 Mil.

Ortin Laboratories's annual Ending Cash Position increased from Mar. 2022 (₹-39.23 Mil) to Mar. 2023 (₹-32.64 Mil) and increased from Mar. 2023 (₹-32.64 Mil) to Mar. 2024 (₹4.59 Mil).

Ortin Laboratories Ending Cash Position Historical Data

The historical data trend for Ortin Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Laboratories Ending Cash Position Chart

Ortin Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

-137.20

-54.75

-39.23

-32.64

4.59

Ortin Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Ortin Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Ortin Laboratories's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	-38.804	+	43.397
	=	4.59

Ortin Laboratories's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

Ortin Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Ortin Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Ortin Laboratories (BOM:539287) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Laboratories Ltd (BOM:539287) » Definitions » Ending Cash Position

Traded in Other Exchanges

ORTINLAB:India

Address

Street no. 3, D. No. 1-8-B4, Ground Floor,Block-4, F3 HIG, Baghlingampally, Hyderabad, TG, IND, 500 044

Website

https://www.ortinlabsindia.com

Ortin Laboratories Ltd is an India based engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its APIs Intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others.It earns key revenue from domestic sales.

Ortin Laboratories (BOM:539287) Headlines

No Headlines